Whitehawk Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $31.3M | $18.8M | $4.5M |
| FY2021 | $21.5M | $157.9M | $149.0M |
| FY2022 | $25.9M | $184.2M | $39.0M |
| FY2023 | $27.2M | $132.4M | $62.9M |
| FY2024 | $17.8M | $70.3M | $28.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $31.3M | $18.8M | $4.5M |
| FY2021 | $21.5M | $157.9M | $149.0M |
| FY2022 | $25.9M | $184.2M | $39.0M |
| FY2023 | $27.2M | $132.4M | $62.9M |
| FY2024 | $17.8M | $70.3M | $28.7M |